{"classes":[{"categories":[{"measurements":[{"groupId":"OG000","lowerLimit":"10.84","upperLimit":"38.45","value":"22.50"}]}]}],"denoms":[{"counts":[{"groupId":"OG000","value":"40"}],"units":"Participants"}],"dispersionType":"95% Confidence Interval","groups":[{"id":"OG000","title":"VDT: VELCADE, Doxil and Low-dose Thalidomide"}],"paramType":"NUMBER","populationDescription":"Evaluable patients.","reportingStatus":"POSTED","timeFrame":"Every 3 months","title":"Complete Response Rate","type":"SECONDARY","unitOfMeasure":"percentage of participants"}